Sign In

QCDR
QOPI
QOPI Reporting Registry

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Sign In
ASCO QOPI

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Sign In

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

Date

CMS Webinar: Eligible Clinician eCQMs with Substantive Changes for the 2019 Performance Year

This one-hour session will provide an in-depth review of electronic clinical quality measures (eCQMs) with substantive changes for the 2019 performance year. The webinar is scheduled on Wednesday, February 27th from 1:00 p.m. to 2:00 p.m. ET. At the end of this eCQMs with substantive changes session, participants will be able to:

Check Your Preliminary 2019 MIPS Eligibility on the QPP Website

You can now check the Quality Payment Program (QPP) Participation Status Tool to view your eligibility status for the 2019 performance period under the Merit-based Incentive Payment System (MIPS). Enter your National Provider Identifier (NPI), to find out if you need to participate in MIPS during the 2019 performance year.

MIPS Participants: Check Payment Adjustments Carefully, Errors May be Present

ASCO has been informed that some oncology practices and providers in the Merit-Based Incentive Payment System (MIPS) have received inaccurate payment adjustments as a result of Medicare Part B drug costs incorrectly being included in the adjustments. The Centers for Medicare & Medicaid Services (CMS) is also aware of the error and is working to resolve the issue. ASCO is in contact with CMS and will continue to keep members informed as a solution is implemented.

Groups Urge HHS, Congress to Reject Proposed Changes to Medicare Part D

ASCO, along with nearly 60 other organizations, joined the American Cancer Society Cancer Action Network (ACSCAN) in an advertising campaign urging a halt to proposed changes to Medicare Part D’s six protected classes. 

What You Need to Know About the Final 2019 Medicare Physician Fee Schedule and Quality Payment Program Rule

Reimbursement cuts in certain oncology specialties. Consolidated payments for certain E&M services. Reduced reimbursement for new Medicare Part B drugs. These are some of the changes coming to the Medicare Physician Fee Schedule and the Quality Payment Program this year. In the latest ASCO in Action Podcast, ASCO CEO Dr. Clifford A. Hudis discusses these changes and what this may mean for your oncology practice.